Gekeler Florian, Szurman Peter, Grisanti Salvatore, Weiler Ulrike, Claus Rolf, Greiner Tim-Oliver, Völker Michael, Kohler Konrad, Zrenner Eberhart, Bartz-Schmidt Karl Ulrich
Centre for Ophthalmology, Schleichstrasse 12-16, 72076 Tübingen, Germany.
Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):230-41. doi: 10.1007/s00417-006-0339-x.
Subretinal implants aim to replace photoreceptor function in patients suffering from degenerative retinal disease like retinitis pigmentosa by topically applying electrical stimuli in the subretinal space. This study-as a last step before upcoming human trials-explored a newly developed surgical technique for permanent implantation of complex subretinal implants with extra-ocular parts.
The implant consisted of a microphoto-diode array (MPDA) with 1550 electrodes and a 4x4 array of gold electrodes for direct electrical stimulation; both were mounted onto a polyimide foil for transscleral placement into the subretinal space. The foil carried connection lanes to a silicone cable that was implanted under the skin and led to a stimulator box in the animal's neck. Surgery was performed in 11 domestic pigs. Improved vitreo-retinal surgical technique consisted of a 180 degrees peripheral retinotomy and use of diathermy to penetrate the choroid in order to avoid choroidal haemorrhage. Subretinal forceps were used to place the implant safely onto the retinal pigment epithelium before the retina was flattened, peripheral laser photocoagulation was applied and the eye was filled with silicon oil. The implant was stabilized by a scleral fixation patch, use of a metal clamp with bone screws on the animal's skull and a tissue ring under the animal's skin in the neck. Behaviour was observed in the freely moving animals after direct subretinal electrical stimulation and funduscopy, optical coherence tomography, fluorescein angiography and histology were performed.
All implants were successfully placed subretinally. In three animals a proliferative vitreo-retinopathy was observed after approximately 2 weeks. Otherwise, funduscopy and OCT demonstrated complete retinal attachment and FA showed no retinal vascular abnormalities over and around the implant. The animals showed clear behavioural reactions to electrical stimulation over the whole examination period. Histological examination failed to show any voltage-induced alteration in the cellular architecture of the retina overlying the stimulation electrodes.
This study demonstrates the feasibility of a new surgical procedure for highly safe and controlled implantation of complex subretinal devices with extra-ocular parts. The new implant design proved to be safely implantable in free-moving pigs for an observation period of 4 weeks.
视网膜下植入物旨在通过在视网膜下间隙局部施加电刺激,来替代患有视网膜色素变性等退行性视网膜疾病患者的光感受器功能。本研究——作为即将进行的人体试验的最后一步——探索了一种用于永久植入带有眼外部分的复杂视网膜下植入物的新手术技术。
该植入物由一个带有1550个电极的微光电二极管阵列(MPDA)和一个用于直接电刺激的4×4金电极阵列组成;两者都安装在聚酰亚胺箔上,以便经巩膜放置到视网膜下间隙。该箔带有连接通道至一根植入皮下的硅胶电缆,该电缆通向动物颈部的刺激器盒。对11头家猪进行了手术。改进的玻璃体视网膜手术技术包括180度周边视网膜切开术,并使用透热法穿透脉络膜以避免脉络膜出血。在视网膜展平之前,使用视网膜下镊子将植入物安全地放置在视网膜色素上皮上,进行周边激光光凝,并向眼内填充硅油。通过巩膜固定贴片、在动物颅骨上使用带骨螺钉的金属夹以及在动物颈部皮肤下使用组织环来固定植入物。在直接视网膜下电刺激后,观察自由活动动物的行为,并进行眼底镜检查、光学相干断层扫描、荧光素血管造影和组织学检查。
所有植入物均成功植入视网膜下。在三只动物中,大约2周后观察到增殖性玻璃体视网膜病变。否则,眼底镜检查和光学相干断层扫描显示视网膜完全附着,荧光素血管造影显示植入物上方及周围无视网膜血管异常。在整个检查期间,动物对电刺激表现出明显的行为反应。组织学检查未能显示刺激电极上方视网膜细胞结构有任何电压诱导的改变。
本研究证明了一种新手术方法的可行性,该方法可高度安全且可控地植入带有眼外部分的复杂视网膜下装置。新的植入物设计被证明可安全植入自由活动的猪体内,并可观察4周。